Kathy Oliver(@KathyOliverIBTA) 's Twitter Profileg
Kathy Oliver

@KathyOliverIBTA

Co-Director, International Brain Tumour Alliance (IBTA); advocate for brain tumour patients and caregivers

ID:55247083

linkhttp://www.theibta.org calendar_today09-07-2009 14:17:00

2,2K Tweets

913 Followers

558 Following

EANO(@EANOassociation) 's Twitter Profile Photo

🗓Abstract submission for closes in 3 DAYS! This is your chance to share your research at the 19th EANO Meeting in amazing Glasgow (UK), and meet outstanding experts in the field of . Learn more & submit: eano.eu/eano2024/abstr…

🗓Abstract submission for #EANO2024 closes in 3 DAYS! This is your chance to share your research at the 19th EANO Meeting in amazing Glasgow (UK), and meet outstanding experts in the field of #NeuroOncology. Learn more & submit: eano.eu/eano2024/abstr… #btsm #glioma #braincancer
account_circle
European Cancer Organisation(@EuropeanCancer) 's Twitter Profile Photo

European Commission 🆕 Just announced at the !
 
Our President Dégi L. Csaba launched ECO’s International Committee
 
➡️Giving strategic oversight to ECO activities & relationships outside Europe
➡️Ensuring global relationships are maintained & enhanced

@EU_Commission 🆕 Just announced at the #EuroAmericanCancerForum2024!   Our President @csabadegi launched ECO’s International Committee   ➡️Giving strategic oversight to ECO activities & relationships outside Europe ➡️Ensuring global relationships are maintained & enhanced #CancerHasNoBorders
account_circle
Lynn M. Schuchter, MD, FASCO(@ASCOPres) 's Twitter Profile Photo

Honored to be in Dublin w/ Julie Gralow ASCO at . I've so enjoyed participating in today's sessions on global cancer care: from comfort to cure, accelerating progress together, and empowering transatlantic cooperation.

Honored to be in Dublin w/ @jrgralow @ASCO at #EuroAmericanCancerForum2024. I've so enjoyed participating in today's sessions on global cancer care: from comfort to cure, accelerating progress together, and empowering transatlantic cooperation. #CancerHasNoBorders
account_circle
AACR(@AACR) 's Twitter Profile Photo

Today, the U.S. FDA granted accelerated approval to the RAF inhibitor tovorafenib for patients 6 months and older with relapsed or refractory pediatric low-grade glioma with certain BRAF alterations. Learn more: bit.ly/4aJF9Jq

account_circle
NCI Cancer Stats(@NCICancerStats) 's Twitter Profile Photo

As of January 1, 2021, 182,520 people in the US were living with a diagnosis. About half of these cancer survivors are under the age of 50. Visit SEER*Explorer to view more cancer statistics: buff.ly/3k5fouk

As of January 1, 2021, 182,520 people in the US were living with a #BrainCancer diagnosis. About half of these cancer survivors are under the age of 50. Visit SEER*Explorer to view more cancer statistics: buff.ly/3k5fouk #BrainTumorThursday
account_circle
UCD Research(@UCD_Research) 's Twitter Profile Photo

Joint Euro-American Forum on Cancer hosts and partners meeting Ireland's Minister for Health Stephen Donnelly at Dublin's Farmleigh House.

📸William Gallagher @UCDDublin All-Island Cancer Research Institute (AICRI), Lynn Schuchter Lynn M. Schuchter, MD, FASCO, Alberto Costa ESOncology European Commission,…

Joint Euro-American Forum on Cancer hosts and partners meeting Ireland's Minister for Health Stephen Donnelly at Dublin's Farmleigh House. #CancerHasNoBorders 📸William Gallagher @UCDDublin @AlCRIproject, Lynn Schuchter @ASCOPres, Alberto Costa @ESOncology @EU_Commission,…
account_circle
CERN Foundation(@CERNfoundation) 's Twitter Profile Photo

This year Ependymoma Awareness Day will be held on May 5.

Get involved by hosting an awareness event in your community or participating in a butterfly art activity at home!

Learn more: cern-foundation.org/awareness/even…

This year Ependymoma Awareness Day will be held on May 5. Get involved by hosting an awareness event in your community or participating in a butterfly art activity at home! Learn more: cern-foundation.org/awareness/even… #CERNButterfly #epENDymoma #BTAM #EpendymomaAwarenessDay
account_circle
NCI Neuro-Oncology Branch(@NIHBrainTumor) 's Twitter Profile Photo

May is Brain Tumor Awareness Month . An estimated 25,050 people will be diagnosed with a cancerous brain tumor this year. Join us as we fill our feed with gray this week to raise awareness and educate others.

Use our guide: go.cancer.gov/03EQKw3.

May is Brain Tumor Awareness Month #BTAM. An estimated 25,050 people will be diagnosed with a cancerous brain tumor this year. Join us as we fill our feed with gray this week to raise awareness and educate others. #GoGrayinMay Use our guide: go.cancer.gov/03EQKw3.
account_circle
Mike Morrissey(@MorrisseyMike) 's Twitter Profile Photo

Very proud of Kathy Oliver Co-Chair of European Cancer Organisation Patient Advisory Committee sharing her experience at Dublin Castle for Euro-American Forum on Cancer. An American woman who’s been living in UK for 50 years and lost her son to a brain tumour. Kathy - you are a legend!

Very proud of @KathyOliverIBTA Co-Chair of @EuropeanCancer Patient Advisory Committee sharing her experience at Dublin Castle for Euro-American Forum on Cancer. An American woman who’s been living in UK for 50 years and lost her son to a brain tumour. Kathy - you are a legend!
account_circle
ESMO Open(@ESMO_Open) 's Twitter Profile Photo

Out in ESMO Open the intracranial activity of T-DXd vs T-DM1 in the DESTINY-Breast03 phase 3 trial. Among patients with active brain mets, IC-ORR was 65.7% with T-DXd vs 34.3% with T-DM1. Accompanied by a podcast 🎙️ & an editorial by Dr Sarah Sammons Nancy Lin, MD. esmoopen.com/article/S2059-…

Out in @ESMO_Open the intracranial activity of T-DXd vs T-DM1 in the DESTINY-Breast03 phase 3 trial. Among patients with active brain mets, IC-ORR was 65.7% with T-DXd vs 34.3% with T-DM1. Accompanied by a podcast 🎙️ & an editorial by @drsarahsam @nlinmd. esmoopen.com/article/S2059-…
account_circle
NCI Center for Cancer Research(@NCIResearchCtr) 's Twitter Profile Photo

Mark Gilbert, M.D., has been a neuro-oncologist for nearly four decades, working to find better treatments for people with rare brain and spine tumors.

After nearly a decade at CCR as chief of NCI Neuro-Oncology Branch, he is announcing his retirement.

👉 go.nih.gov/L3R1TC9

Mark Gilbert, M.D., has been a neuro-oncologist for nearly four decades, working to find better treatments for people with rare brain and spine tumors. After nearly a decade at CCR as chief of @NIHBrainTumor, he is announcing his retirement. 👉 go.nih.gov/L3R1TC9
account_circle